UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Psychopharmacology, ISSN 0033-3158, 12/2012, Volume 224, Issue 4, pp. 489 - 499
Nicotinic | Neurosciences | Impulsivity | Perseveration | Biomedicine | Muscarinic | Risk | Delay discounting | Pharmacology/Toxicology | Psychiatry | Cholinergic | Probability discounting | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Choice Behavior - drug effects | Nicotine - administration & dosage | Rats, Long-Evans | Decision Making - drug effects | Probability | Rats | Atropine - pharmacology | Male | Nicotine - pharmacology | Dose-Response Relationship, Drug | Muscarinic Antagonists - administration & dosage | Nicotinic Agonists - administration & dosage | Scopolamine Hydrobromide - pharmacology | Animals | Muscarinic Antagonists - pharmacology | Cost-Benefit Analysis | Scopolamine Hydrobromide - administration & dosage | Atropine - administration & dosage | Reward | Nicotinic Agonists - pharmacology | Decision-making | Economic aspects | Schizophrenia | Cost benefit analysis | Attention-deficit hyperactivity disorder | Drug addiction | Behavioral decision theory | Psychopharmacology | Benefit cost analysis | Index Medicus | Scopolamine | Acetylcholine receptors (muscarinic) | Mental disorders | Decision making | Therapeutic applications | Attention deficit hyperactivity disorder | Data processing | Antagonists | mecamylamine | oxotremorine | Addiction | Etiology | Acetylcholine receptors | Atropine | Reinforcement | Acetylcholine receptors (nicotinic) | Cholinergic transmission | Nicotine
Journal Article
2.
Full Text
α7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
Annual review of medicine, ISSN 0066-4219, 1/2014, Volume 65, Issue 1, pp. 245 - 261
olanzapine | chromosome human pair 15 | clozapine | CHRNA7 | autism | smoking | Autism | Olanzapine | Chromosome human pair 15 | Clozapine | Smoking | Memory - drug effects | Sensory Gating - drug effects | Humans | Fetal Development | alpha7 Nicotinic Acetylcholine Receptor - genetics | alpha7 Nicotinic Acetylcholine Receptor - agonists | Eye Movements - drug effects | Cognition - drug effects | Nicotinic Agonists - therapeutic use | Nicotine - pharmacology | Animals | Benzylidene Compounds - pharmacology | Schizophrenia - genetics | Benzylidene Compounds - therapeutic use | Attention - drug effects | Pyridines - pharmacology | alpha7 Nicotinic Acetylcholine Receptor - metabolism | Schizophrenia - drug therapy | Nicotinic Agonists - pharmacology | Pyridines - therapeutic use | Schizophrenia | Physiological aspects | Acetylcholine | Dosage and administration | Cognition | Drug therapy | Health aspects | Index Medicus
Journal Article
Journal of neurochemistry, ISSN 0022-3042, 08/2010, Volume 114, Issue 4, pp. 1205 - 1216
Journal Article
Journal of psychiatric practice, ISSN 1527-4160, 01/2014, Volume 20, Issue 1, pp. 12 - 24
evoked response potentials | proof of concept study | computerized cognitive testing | antipsychotics | cognitive impairment | schizophrenia | alpha-7 nicotinic receptor partial agonist | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Thiophenes - adverse effects | Humans | Middle Aged | Male | Schizophrenia - complications | Cognition | Thiophenes - administration & dosage | Quinuclidines - administration & dosage | Young Adult | Schizophrenia - physiopathology | Cognition Disorders - etiology | Adult | Female | Drug Therapy, Combination | Quinuclidines - adverse effects | Cognition Disorders - physiopathology | Double-Blind Method | Quinuclidines - pharmacology | Thiophenes - pharmacology | Treatment Outcome | alpha7 Nicotinic Acetylcholine Receptor - agonists | Cognition Disorders - drug therapy | Antipsychotic Agents - administration & dosage | Evoked Potentials - drug effects | Adolescent | Schizophrenia - drug therapy | Index Medicus
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 10/2014, Volume 289, Issue 44, pp. 30538 - 30555
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Disks Large Homolog 4 Protein | Liver - pathology | Nicotinic Acids - pharmacokinetics | Humans | Male | Tetrahydronaphthalenes - adverse effects | ATP Binding Cassette Transporter 1 - metabolism | Liver - drug effects | Tetrahydronaphthalenes - administration & dosage | Amyloid beta-Peptides - metabolism | Lipoproteins - metabolism | ATP-Binding Cassette Transporters - metabolism | Membrane Proteins - metabolism | Nicotinic Acids - administration & dosage | Drug Evaluation, Preclinical | Nicotinic Acids - adverse effects | Retinoid X Receptors - metabolism | ATP Binding Cassette Transporter, Subfamily G, Member 1 | Bexarotene | Peptide Fragments - metabolism | Administration, Oral | Mice, Inbred C57BL | Solubility | Alzheimer Disease - drug therapy | Tetrahydronaphthalenes - pharmacokinetics | Genotype | Mice, Transgenic | Organ Size - drug effects | Animals | Retinoid X Receptors - agonists | Apolipoproteins E - genetics | Guanylate Kinases - metabolism | Index Medicus | ABCA1 | Molecular Bases of Disease | Oligomeric Aβ | Alzheimer Disease | Drug Delivery | Aβ Complex | Apolipoprotein E (ApoE) | Amyloid-β (AB) | RXR Agonists | Hepatomegaly | ABCG1 Lipid Transporters | Drug Action | ApoE
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 06/2010, Volume 53, Issue 11, pp. 4379 - 4389
Urea - pharmacokinetics | Humans | Pyridines - pharmacokinetics | Substrate Specificity | Male | Structure-Activity Relationship | Urea - chemical synthesis | Receptors, Nicotinic - chemistry | Urea - analogs & derivatives | Inhibitory Concentration 50 | Nicotinic Agonists - pharmacology | Urea - administration & dosage | Receptors, Nicotinic - metabolism | Pyridines - administration & dosage | Administration, Oral | Pyridines - chemical synthesis | Models, Molecular | Rats | Nicotinic Agonists - administration & dosage | Animals | Nicotinic Agonists - chemical synthesis | Protein Conformation | Pyridines - pharmacology | Nicotinic Agonists - pharmacokinetics | Urea - pharmacology | alpha7 Nicotinic Acetylcholine Receptor | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, pp. CD006103 - CD006103
Interventions to help smokers and other tobacco users to quit | Lungs & airways | Pharmacological interventions | Varenicline | Substance Withdrawal Syndrome | Azepines | Randomized Controlled Trials as Topic | Heterocyclic Compounds, 4 or More Rings | Alkaloids | Quinolizines | Tobacco, drugs & alcohol | By treatment type | Tobacco | Azocines | Bupropion | Benzazepines | Nicotinic Agonists | Counseling | Medications | Medicine General & Introductory Medical Sciences | Nicotine | Smoking | Smoking Cessation | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Humans | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use | Index Medicus
Journal Article